Using the drug esmolol, a fast acting, water-soluble beta-1 adrenergic blocking agent, it is possible to control tachycardia in patients during general anesthesia and post-operative.y. the goal of the phase i research is to generate a closed-loop system to control tachycardia using esmolol. theā¦
More